Form D · Biotechnology
ARCXIS BIOTECHNOLOGIES
Pleasanton, CA · CIK 0001367726
Offering snapshot reported May 25, 2010 · SEC filing
- Reported sold
- $1.44M Offering amount: $2.34M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 1, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 25, 2010 | Initial | $1,440,000 | No comparison | 5 | SEC filing |
| Jan 21, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 22, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 14, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-142528
Source: Form D, filed May 25, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Chris M. Grant | Director |
| Kyle Hukari | Executive |
| Christine A. Meda | Director, Executive |
| John Stuart | Director |
| Jason A.A. West | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6920 Koll Center Parkway Suite 215 216
Pleasanton, CA, 94566
Pleasanton, CA, 94566